Pharmafile Logo
Pharmafocus logo
Advanced Search
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

July 15, 2020
Research and Development COVID-19, coronavirus, vaccines

The coronavirus news this week focuses on therapeutics, with Gilead’s remdesivir reducing the risk of death in 62% of severe …

News
masksss

People in England must wear face mask in shops from 24 July

July 14, 2020
Manufacturing and Production coronavirus, masks

Face masks are set to become mandatory in shops across England beginning on 24 July, following months of mixed messaging …

News
shutter

Malaria prophylactic tafenoquine shows antiviral activity against SARS-CoV-2 in cell cultures

July 14, 2020
Manufacturing and Production, Research and Development 60 Degrees Pharmaceuticals, COVID-19, coronavirus, pharma

Specialist tropical disease drug firm 60 Degrees Pharmaceuticals has revealed that its therapy Arakoda (tafenoquine) has been shown in cell …

News
trialllllssss

Arthritis drug reduces COVID-19 deaths for patients on ventilators

July 14, 2020
Manufacturing and Production COVID-19, coronavirus

The rheumatoid arthritis drug tocilizumab reduces death rates in coronavirus patients on ventilation, according to new studies. 

News
shutterstock_273326141

Roche and Blueprint extend collaboration with $1.7 billion cancer drug development and commercialisation deal

July 14, 2020
Manufacturing and Production, Research and Development Blueprint Medicines, Cancer, Roche, pralsetinib

Roche and Blueprint Medicines have come together in a $1.7 billion development and commercialisation partnership focused on precision therapy pralsetinib …

News
pfizer_finland_hq_february_13_2009_1

Pfizer and BioNTech’s COVID-19 vaccines to have their development fast tracked by the FDA

July 14, 2020
Manufacturing and Production, Research and Development COVID-19, Vaccine, coronavirus

The FDA has granted Pfizer and BioNTech’s COVID-19 vaccine candidates Fast Track status to speed up their development and review. …

News
shutterstock_38078521

Itolizumab “significantly reduced mortality” in hospitalised COVID-19 patients with respiratory distress, secures emergency use authorisation in India

July 13, 2020
Research and Development, Sales and Marketing COVID-19, Itolizumab, coronavirus

Itolizumab, a drug currently being developed by biotech firm Equillium for autoimmune and inflammatory disorders, “significantly reduced mortality” in hospitalised …

News
pfizer_finland_hq_february_13_2009_1

WHO reports record daily increase in global COVID-19 cases

July 13, 2020
Sales and Marketing COVID-19, coronavirus

The World Health Organization reported the largest daily increase in COVID-19 cases since the pandemic began. Over the weekend there …

News
russr

Russia claims it has completed the first human trial for COVID-19 vaccine

July 13, 2020
Sales and Marketing COVID-19, coronavirus, vaccines

Russia has become the first country to complete a COVID-19 vaccine trial on humans, according to the Russian News Agency. …

News
remsss

Remdesivir cuts death risk by 62% in coronavirus patients, new study shows

July 13, 2020
Sales and Marketing COVID-19, coronavirus

Gilead’s remdesivir reduced the risk of death in 62% of severe COVID-19 patients, according to a new study. The company …

News
tecentriq

Roche’s Tecentriq fails to hit main Phase 3 goal in front-line ovarian cancer

July 13, 2020
Research and Development, Sales and Marketing Genentech, Roche, ovarian cancer, tecentriq

Roche subsidiary Genentech has revealed that its immunotherapy Tecentriq (atezolizumab), combined with Avastin (bevacizumab), paclitaxel and carboplatin, fell short of …

News
edwin

Dr Edwin Moses appointed as Chairman of the Board of Sensorin

July 10, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Sensorin have appointed Dr Edwin Moses as the Chairman of its Board of Directors Moses joins from his previous role …

Appointment
shutterstock_159488225

New data shows Gilead’s remdesivir “potently inhibited” SARS-CoV-2 in human lung cell cultures

July 10, 2020
Medical Communications, Research and Development COVID-19, Gilead, coronavirus, remdesivir

New findings published from researchers at Vanderbilt University Medical Center (VUMC) at the University of North Carolina, as well as …

News
brain

Scientists warn of brain damage linked to COVID-19

July 10, 2020
Medical Communications COVID-19, Neurological, coronavirus

COVID-19 could lead to a wave of brain damage in people who were infected with the virus. Experts at the …

News
shutterstock_gonnorrhea

Industry comes together to form the AMR Action Fund, pledging $1bn to fight antimicrobial resistance

July 10, 2020
Medical Communications, Research and Development AMR, antimicrobial resistance, biotech, pharma

Over 20 biopharma firms have come together to launch the AMR Action Fund, an initiative of the International Federation of …

News
world

The World Health Organization says COVID-19 can linger in the air indoors

July 10, 2020
Medical Communications COVID, COVID-19, WHO, coronavirus

The World Health Organization has recoginised that COVID-19 can be transmitted indoors by droplets in the air, reversing its previous …

News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

July 10, 2020
Medical Communications coronavirus, covid19, top 10

The World Health Organization features prominently in the news this week, as it discontinued trials into the viability of hydroxychloroquine, …

News

J&J under fire from 170 nonprofits to halt baby powder sales worldwide because it contains asbestos

July 9, 2020
Sales and Marketing Cancer, J&J, JJ, pharma, talc

In the latest chapter in Johnson & Johnson’s talc-related woes, the company is being pressured by group of over 170 …

News

NICE recommends Takeda’s Adcetris for previously untreated systemic anaplastic large cell lymphoma

July 9, 2020
Sales and Marketing Adcentris, NICE, Takeda, UK

NICE has announced it has recommended Takeda’s Adcetris (brentuximab vedotin), in combination with cyclophosphamide, doxorubicin and prednisone (CHP), for use …

News
regeneron

Regeneron seals $450m BARDA contract to scale up production of its COVID-19 vaccine

July 9, 2020
Manufacturing and Production, Sales and Marketing BARDA, Operation Warp Speed, Regeneron, US, vaccine COVID-19

Regeneron has revealed that REGN-COV2, its two-antibody vaccine for the treatment and prevention of COVID-19, has been awarded a manufacturing …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026